Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Directions
This review critically examines dietary bioactives alzheimer s disease clinical trials, focusing on cannabinoids and other compounds. It provides clinicians with an evidence-based assessment to distinguish promising treatments from marketing claims.…
A&S scholars sharing their expertise in the media | Faculty of Arts & Science
This article highlights academic cannabis media coverage featuring Faculty of Arts & Science scholars sharing their expertise. It focuses on emerging cannabis research and clinical developments. The coverage provides valuable insights into cannabis…
More than a decade after recreational cannabis was legalized in Washington, a new survey …
Post-legalization cannabis surveillance is critical for understanding health outcomes after Washington legalized recreational cannabis. This survey examines population health impacts more than a decade later. Clinical interpretation requires rigorous…
Exploring Neuroprotective Cannabis Clinical Trials and Their Impact
Neuroprotective cannabis clinical trials are advancing research into treatments for neurological disorders. These trials explore cannabis compounds' potential to protect nerve cells. Understanding clinical evidence helps guide safe and effective use.
Judge Denies SAM’s Temporary Restraining Order; CBD Pilot Program Launches
CBD pilot programs represent controlled opportunities to generate real-world safety and efficacy data under regulatory oversight. A judge has denied SAM's request for a temporary restraining order, allowing the CBD pilot program to proceed. These…
Germany: CDU/CSU calls for cannabis rethink 2 years in – DW.com
Germany's cannabis legalization in 2024 is a major policy experiment with significant clinical interest. The CDU/CSU party now calls for a reassessment of this framework. This german cannabis legalization development could influence global cannabis…
Insights from the 2024 Cannabis Research Conference
The 2024 cannabis research conference showcases emerging clinical research and evidence-based medicine developments. This event is pivotal for clinicians seeking the latest therapeutic insights. Attendees gain valuable updates to inform patient care…
CannMed 26 Celebrates 10th Anniversary Amid Industry Uncertainty
CannMed 26 clinical cannabis education marks a decade of advancing therapeutic knowledge despite regulatory challenges. This milestone highlights sustained clinical interest in cannabis therapeutics. The conference remains a vital platform for…
How to Live Like It’s the ’90s | ABS-CBN Metro.Style
This article provides cannabis clinical relevance updates focusing on emerging findings and notable clinical interest. Healthcare professionals should monitor these updates closely. The content supports evidence-based clinical decision-making.
Iceland Is Too Smart for Lazy Cannabis Panic: Inside the Hemp4Future Conference
Iceland cannabis policy development is setting a new standard with its evidence-based approach. The Hemp4Future Conference highlights how Iceland evaluates therapeutic cannabis without panic. This model offers valuable insights for jurisdictions…